SEC Form 4 · accession 0001022079-18-000151
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Everett Cunningham
Officer — SVP, Commercial
Period of report
Jul 2, 2018
Accepted (ET)
Jul 5, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 2, 2018 | M | 21,294 | $52.165 | A | 67,210 | D | |
| Common StockF2 | Jul 2, 2018 | S | 19,798 | $109.642 | D | 47,412 | D | |
| Common StockF3 | Jul 2, 2018 | S | 1,496 | $110.122 | D | 45,916 | D | |
| Common Stock | Jul 2, 2018 | M | 38,928 | $66.51 | A | 84,844 | D | |
| Common StockF4 | Jul 2, 2018 | S | 33,345 | $109.596 | D | 51,499 | D | |
| Common StockF5 | Jul 2, 2018 | S | 5,583 | $110.066 | D | 45,916 | D | |
| Common StockF6 | Jul 2, 2018 | S | 7,066 | $109.627 | D | 38,850 | D | |
| Common StockF7,F8 | Jul 2, 2018 | S | 781 | $110.124 | D | 38,261 | D | |
| Common StockF9 | holding | — | — | — | 616 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualifed Stock Option (right to buy)F10 | $52.165 | Jul 2, 2018 | M | 21,294 | D | — | Feb 13, 2024 | Common Stock | 21,294 | 0 | D |
| Non-Qualifed Stock Option (right to buy)F11 | $66.51 | Jul 2, 2018 | M | 38,928 | D | — | Feb 25, 2026 | Common Stock | 38,928 | 19,464 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 31, 2018.
- F10The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017.
- F11The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
- F2This transaction was executed in multiple trades at prices ranging from $109.07 to $110.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $110.07 to $110.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $109.00 to $110.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $110.00 to $110.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $109.08 to $110.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $110.08 to $110.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F9These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.